Modulation of microRNAs in hypertension-induced arterial remodeling through the β1 and β3-adrenoreceptor pathways

Keyphrases

• Aberrant Expression 16%
• Adrenoceptor Antagonist 16%
• Adrenoceptors 100%
• Antisense Inhibitor 16%
• Aorta 33%
• Arterial Dysfunction 33%
• Arterial Hypertension 16%
• Arterial Remodeling 100%
• Atenolol 16%
• Beta-blockers 66%
• BRL37344 16%
• Computational Analysis 16%
• Dahl Salt-sensitive 16%
• Diet-induced 16%
• Dysregulated 16%
• Dysregulation 16%
• Endothelial Nitric Oxide Synthase (eNOS) 16%
• Expression Profile 16%
• Gene Expression 16%
• High Salt 16%
• High-salt Diet 16%
• Hypertension 100%
• Hypertensive 16%
• Hypertensive Rats 16%
• Insulin-like Growth Factor 1 Receptor (IGF1R) 66%
• Luciferase Reporter Assay 16%
• Microarray Analysis 16%
• MicroRNA 100%
• MiR-26a 66%
• MiR-320a 83%
• MiRNA Expression 33%
• Nebivolol 16%
• Overexpression 33%
• Oxidative Stress 16%
• Partial Effects 16%
• Phosphatase 16%
• Protective Effect 16%
• Putative Targets 33%
• Rat Model 16%
• Receptor Expression 16%
• Salt-sensitive Hypertension 33%
• Stress Remodeling 16%
• Tensin Homolog 16%
• Vascular Remodeling 16%

Pharmacology, Toxicology and Pharmaceutical Science

• 4 [2 [[2 (3 Chlorophenyl) 2 Hydroxyethyl]amino]propyl]phenoxyacetic Acid 12%
• Adrenergic Receptor 100%
• Antihypertensive Agent 12%
• Atenolol 12%
• Cyanopindolol 12%
• Dahl Salt Sensitive Rat 12%
• Fibrinogen 50%
• Luciferase 12%
• microRNA 100%
• Nebivolol 12%
• Phosphatase 12%
• Rat Model 12%
• Receptor 50%
• Somatomedin 50%
• Table Salt 50%
• Tensin 12%
• Vascular Remodeling 12%